Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
A class-action lawsuit filed earlier this month claims that Blue Shield of California stiffed consumers on more than $34 million dollars in refunds on premiums they paid in 2014.
On the heels of healthcare reform, 2016 be-gan with the expansion of the small-group employer category—the bedrock of the U.S. economy.
Health insurance rates through the Covered California insurance exchange will be rising between 8.4 percent and 10.8 percent on average next year in the central San Joaquin Valley, the exchange announced Tuesday.
California’s Obamacare premiums will jump 13.2 percent on average next year, a sharp increase that is likely to reverberate nationwide in an election year.
Provider directories for some health plans sold through Covered California and in the private market are so inaccurate that they create an “awful” situation for consumers trying to find doctors, according to the lead author of a new study published in the journal Health Affairs.
With Californians facing the busiest ballot in more than a decade, big spenders are poised to make it one of the most expensive election battles in state history -- already contributing $185 million to fight over everything from sex, drugs and guns to tobacco and taxes.
A new study takes a fresh measure of generic drugs’ price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.
The Obama administration knowingly spent billions in health care dollars without proper congressional authority and went to “great lengths” to impede congressional scrutiny of the money, Republicans on two major House committees said in a report that will be made public on Thursday.
A federal appeals court has ruled that consumers must be allowed to buy certain types of health insurance that do not meet the stringent standards of the Affordable Care Act, deciding that the administration had gone beyond the terms of federal law.
The latest study of medicine prices finds U.S. insurers' spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled.